2020
DOI: 10.3389/fphar.2020.01066
|View full text |Cite
|
Sign up to set email alerts
|

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China

Abstract: Background: Coronavirus Disease 2019 (COVID-19) is an emerging and rapidly evolving disease, with no recommended effective anti-coronavirus drug treatment. Traditional Chinese Patent Medicines (CPMs) have, however, been widely used to treat COVID-19 in China, and a number of clinical practice results have shown them to have a significant role in its treatment. Consequently, numerous guidelines and expert consensus have recommended the use of CPMs to treat COVID-19. Aim of the Study: The objectives of this revi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
74
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 83 publications
(74 citation statements)
references
References 124 publications
0
74
0
Order By: Relevance
“…Nowadays, traditional Chinese patent medicines (CPMs) that contain various natural compounds have been used to treat COVID-19 to prevent virus, inflammation and lung injury. These CPMs such as Tanreqing injection (TRQI), Lianhua Qingwen capsule (LHQWC) and Xuebijing injection (XBJI) have good therapeutic efficacy in COVID-19 treatment [ 420 ].…”
Section: Potential Clinical Use Of Natural Compounds For Alimentioning
confidence: 99%
“…Nowadays, traditional Chinese patent medicines (CPMs) that contain various natural compounds have been used to treat COVID-19 to prevent virus, inflammation and lung injury. These CPMs such as Tanreqing injection (TRQI), Lianhua Qingwen capsule (LHQWC) and Xuebijing injection (XBJI) have good therapeutic efficacy in COVID-19 treatment [ 420 ].…”
Section: Potential Clinical Use Of Natural Compounds For Alimentioning
confidence: 99%
“…Furthermore, there are many other proprietary traditional Chinese medicine products also play an important therapeutic role by direct antiviral actions, antipyretic and analgesic, immune-regulation, antiinflammation, and anti-acute lung injury, such as Agastache Qi-Correcting Capsule (Huoxiang Zhengqi Jiaonang), Lonicera Fever-clearing Granule (Jinhua Qinggan Keli), Wind-scattering Toxin-resolving Capsule (Shufeng Jiedu Jiaonang), Xiyanping Injection (Xiyanping Zhusheye), Blood-clearing Injection (Xuebijing Zhusheye), Ginseng and Aconite Injection (Shenfu Zhusheye), Ginseng and Ophiopogon Injection (Shenmai Zhusheye), Peaceful Palace Bovine Bezoar Pill (Angong Niuhuang Wan), etc. (Zhuang et al, 2020).…”
Section: Tcm For the Treatment Of Coronavirus Induced Disease 2019 (Cmentioning
confidence: 99%
“…The WHO proposed A. annua as a possible treatment to be considered for COVID-19 treatment, however its efficacy and side-effects must be determined. Additionally, A. annua is one of the of Jinhua Qinggan granule ingredients, one of the Traditional Chinese Patent Medicines recommended in 13 therapeutic regimens of COVID-19 in China [ 305 ]. The A. argyi it was also mentioned as one of the plants that can be used by aromatherapy method of Traditional Chinese Medicine with effects of contagion prevention [ 306 ].…”
Section: Hotpoint Research: Artemisia Species Amentioning
confidence: 99%